Barclays Issues Pessimistic Forecast for Acadia Healthcare (NASDAQ:ACHC) Stock Price

Acadia Healthcare (NASDAQ:ACHC) had its target price trimmed by Barclays from $76.00 to $43.00 in a research report report published on Friday morning,Benzinga reports. The firm currently has an overweight rating on the stock.

Other equities analysts also recently issued research reports about the company. Cantor Fitzgerald reiterated a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Royal Bank of Canada lowered their price target on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research report on Monday, November 18th. StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Friday. Deutsche Bank Aktiengesellschaft increased their price target on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Finally, KeyCorp began coverage on Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. One investment analyst has rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $79.67.

Acadia Healthcare Stock Up 4.6 %

Shares of ACHC opened at $39.99 on Friday. Acadia Healthcare has a 52 week low of $36.50 and a 52 week high of $87.77. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The company has a market capitalization of $3.71 billion, a price-to-earnings ratio of 13.11, a PEG ratio of 1.69 and a beta of 1.33. The stock’s 50-day moving average price is $53.36 and its 200-day moving average price is $64.32.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. During the same quarter in the prior year, the business earned $0.91 earnings per share. The company’s revenue was up 8.7% compared to the same quarter last year. On average, sell-side analysts predict that Acadia Healthcare will post 3.38 EPS for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ACHC. Russell Investments Group Ltd. increased its stake in Acadia Healthcare by 9.7% during the first quarter. Russell Investments Group Ltd. now owns 9,876 shares of the company’s stock worth $782,000 after acquiring an additional 875 shares during the last quarter. CANADA LIFE ASSURANCE Co grew its stake in shares of Acadia Healthcare by 14.7% in the first quarter. CANADA LIFE ASSURANCE Co now owns 58,505 shares of the company’s stock valued at $4,637,000 after buying an additional 7,491 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of Acadia Healthcare by 2.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 133,093 shares of the company’s stock valued at $10,545,000 after buying an additional 2,584 shares in the last quarter. Iron Triangle Partners LP grew its stake in shares of Acadia Healthcare by 14.0% in the first quarter. Iron Triangle Partners LP now owns 902,813 shares of the company’s stock valued at $71,521,000 after buying an additional 110,820 shares in the last quarter. Finally, Cetera Advisors LLC acquired a new stake in shares of Acadia Healthcare in the first quarter valued at $540,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.